Vestmark Advisory Solutions, Inc.
Position in RDY — Dr Reddys Laboratories Ltd
CIK 1736982
Wakefield, MA
Position in RDY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$317,885
-$159,329 QoQ
Shares Held
22,952
-36.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Vestmark Advisory Solutions, Inc. holds $14,377,327 across 11 Drug Manufacturers - Specialty & Generic names. RDY ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
345,822 | $6,404,623 | |
| 2 | HLN |
Haleon plc
|
325,158 | $3,254,830 | |
| 3 | ZTS |
Zoetis Inc.
|
11,199 | $1,323,833 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
16,788 | $1,290,997 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,274 | $731,132 | |
| 6 | VTRS |
Viatris Inc
|
42,463 | $573,675 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
This page
|
22,952 | $317,885 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
12,754 | $305,203 |
All Filings in RDY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $317,885 | 22,952 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $477,214 | 36,180 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $251,408 | 15,922 | Shares | Other | 2025-02-06 | |
| 2024-09-30 | $65,895 | 4,147 | Shares | Other | 2024-11-14 | |
| 2020-12-31 | $69,008 | 4,840 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $65,664 | 4,720 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $47,836 | 4,512 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||